ArticleIntestinal research2022

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study.

Vitaliy Y Poylin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.